Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hepatitis B virus capsid assembly involves precise self-association of core proteins into an ordered structure that protects viral genetic material throughout its life cycle. Both structural domains—the NTD driving physical assembly and CTD mediating nucleic acid interactions—are crucial for function. Disrupting this finely tuned process through small-molecule modulators offers a validated approach for antiviral therapy against hepatitis B virus infections.
Disruption of capsid assembly, leading to aberrant/incomplete particles or stabilization of non-functional assemblies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hepatitis B Virus Capsid Assembly (HBV Capsid Assembly).